About Barosense
Barosense is a company based in Redwood City (United States) founded in 2001 was acquired by Boston Scientific in March 2015. Barosense has raised $45.69 million across 4 funding rounds from investors including Boston Scientific, Frazier Healthcare Partners and Inovia Capital. Barosense operates in a competitive market with competitors including Apollo Endo, USGI Medical, ReShape, Vibrynt and Satiety, among others.
- Headquarter Redwood City, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$45.69 M (USD)
in 4 rounds
-
Latest Funding Round
Not available
-
Investors
Boston Scientific
& 9 more
-
Employee Count
Not available
-
Acquired by
Boston Scientific
(Mar 02, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Barosense
Barosense has successfully raised a total of $45.69M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Barosense
Barosense has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include Boston Scientific, Frazier Healthcare Partners and Inovia Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in early-stage technology companies by Inovia Capital.
|
Locked | Locked | Locked | |
|
Investments are made in life sciences firms across all stages.
|
Locked | Locked | Locked | |
|
Healthcare sector private equity investments are managed by the firm.
|
Locked | Locked | Locked |
Investor details for Barosense
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Barosense
Investment portfolio details for Barosense
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Barosense
Detailed financials for Barosense
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Barosense Comparisons
Peer comparison for Barosense
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Barosense
Barosense operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Apollo Endo, USGI Medical, ReShape, Vibrynt and Satiety, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutic devices for obesity and GI disorders are developed.
|
|
| Locked | Locked | Locked |
Incisionless operating platform for weight loss surgery
|
|
| Locked | Locked | Locked |
A dual intra-gastric balloon system is provided for weight loss.
|
|
| Locked | Locked | Locked |
Provides durable coat hooks and storage solutions for home use.
|
|
| Locked | Locked | Locked |
Develops a device for transoral gastroplasty to induce satiety through endoscopic methods.
|
Detailed competitors of Barosense
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Barosense
Complete news archive for Barosense
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Barosense
Barosense was founded in 2001 and raised its 1st funding round 1 year after it was founded.
Barosense is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Barosense is a funded company, having raised a total of $45.69M across 4 funding rounds to date.
BaroSense is focused on developing and commercializing anti-obesity products. BaroSense product Teris was developed using two key surgical findings: Stomach restriction is effective in reducing weight Serosal to serosal stomach apposition produces durable stomach modification. It develops minimally invasive therapeutic weight loss procedures and devices, including investigational trans-oral endoscopic restrictive implant system and a trans-oral (through the mouth) procedure that places a soft (tissue) silicone device in the stomach that induces a feeling of fullness with a small meal. Currently limited by Federal (or United States) law to investigational use. The company does not seem to be active currently.
Barosense's top competitors include Apollo Endo, ReShape and USGI Medical.
Barosense has 10 investors. Key investors include Boston Scientific, Frazier Healthcare Partners, Inovia Capital, Delphi Ventures, and RWI Ventures.